Several studies also indicated that isorhamnetin, a derivative of rhamnetin, suppresses the ERK1/2 pathway to process its biological effects, such as anti-oxidative stress, inhibiting tumor invasion and migration, and blocking epithelial-to-mesenchymal transition [23,24,61]. This evidence concerns the gene MAPK3 and neoplasm.